两种乳酸菌胞外多糖对人体粪便菌群的影响

目的 在体外利用7名志愿者的新鲜粪便作为来源,选择菊粉作为对照,研究干酪乳杆菌LC2W与鼠李糖乳杆菌Y37胞外多糖对人体肠道菌群的影响.方法 利用PCR-DGGE(变性梯度凝胶电泳)方法分析样品中菌群组成,高效液相色谱分析培养前后胞外多糖组分变化.结果 与菊粉相比,粪便菌群在添加乳杆菌胞外多糖培养后,Parabacteroides类群细菌明显增加,4名志愿者粪便样品中出现明显的双歧杆菌条带,两种乳杆菌胞外多糖对粪便菌群的影响差异无统计学意义;而添加菊粉培养后,Bacteroides类群细菌的条带明显增加.两种乳杆菌胞外多糖中主要是大分子量的部分被利用.结论 干酪乳杆菌LC2W与鼠李糖乳杆菌Y37的胞外多糖在体外有调节粪便菌群的作用.     

营养因子对干酪乳杆菌LC2W胞外多糖合成的影响

针对影响干酪乳杆菌LC2W产胞外多糖的主要营养因子:葡萄糖、酪蛋白胨和酵母提取物进行了单因素及正交试验,确定了合成胞外多糖的最适组成为葡萄糖60 g/L,酪蛋白胨16 g/L ,酵母提取物10 g/L,其中酪蛋白胨影响差异极显著.验证试验表明,以优化后的培养基进行发酵试验,37 ℃培养24 h,所得胞外多糖量为120.37 mg/L,较原来提高67.97 %.     

双歧杆菌胞外多糖研究进展

双歧杆菌是一种众所周知、使用范围很广的商用益生菌,其生长繁殖贯穿人的整个生命过程。有研究表明双歧杆菌具有益生功能的主要分子机制依赖于双歧杆菌自身分泌的胞外多糖。尽管一些细菌胞外多糖已经商业化用于食品和医药保健品等领域,如黄原胶、透明质酸和右旋糖苷等,但双歧杆菌等常用益生菌的胞外多糖还鲜见有商业化应用的报道。本文综述了双歧杆菌胞外多糖的合成分子机制、单糖组成及其理化性质,分析了双歧杆菌胞外多糖对肠道菌群的调节作用,阐述了双歧杆菌胞外多糖在抗氧化、改善和提高宿主免疫、抗过敏、抗肿瘤以及降低胆固醇等方面所体现出的益生功能。同时也对双歧杆菌胞外多糖分子机制研究和产业化开发方面存在的一些问题进行了讨论。     

乳杆菌胞外多糖合成基因簇及构效关系

肠道菌群稳态对维护人体的健康具有至关重要的作用。作为肠道天然微生物群“守卫兵”,益生菌参与改善体内微生态平衡。乳杆菌(Lactobacillus)是一种肠道益生菌的代表,其合成的胞外多糖(exopolysaccharide, EPS)既可通过增益肠道内其他益生菌的生长来优化肠道微生态,还具有抗肿瘤、抗氧化、降胆固醇、降血压和增强机体免疫力等益生功能。本文对近年来乳杆菌胞外多糖的遗传、生物学活性、构效关系等方面的研究进展,进行综述和展望。     

不同碳源对干酪乳杆菌LC2W胞外多糖组成影响的研究

运用紫外光谱、红外光谱、HPLC和气相色谱对葡萄糖和乳糖两种碳源获得的胞外多糖(EPS)单一组分G1、G2和L1、L2的结构进行了初步分析。结果显示不同碳源对EPS的分子结构、分子量和单糖组成都有影响。紫外光谱分析都不含蛋白和核酸;红外光谱分析G1、G2和L1、L2均呈现多糖的特征峰,但波形、特征吸收波段、波峰强度有些差异;HPLC测定G1、G2、L1和L2的平均分子量分别为6.65×105Da、1.01×104Da、2.25×106Da和1.36×104Da;气相色谱分析G1、G2和L1、L2的主要单糖组成摩尔比分别为:鼠李糖∶葡萄糖∶半乳糖=3.07∶3.29∶1;鼠李糖∶葡萄糖∶半乳糖=2.84∶6.4∶1;甘露糖∶葡萄糖∶半乳糖=17.24∶6.03∶1;甘露糖∶葡萄糖∶半乳糖=28.71∶5.98∶1。     

植物乳杆菌C88胞外多糖生物合成基因的克隆及序列比对

乳酸菌胞外多糖能显著改善发酵乳制品及食品的流变学和质构特性.为进一步了解乳酸菌胞外多糖的生物合成途径及调控机制,本研究对参与植物乳杆菌C88胞外多糖生物合成基因簇的部分序列进行了克隆和鉴定.根据GenBank中已报道植物乳杆菌基因序列的保守区域设计特异性引物,扩增出植物乳杆菌C88生物合成蛋白基因(cps4A)序列,并通过染色体步移方法克隆了植物乳杆菌C88 参与胞外多糖合成基因簇的部分序列(4.9 kb).利用生物信息学方法预测基因簇中6个阅读框的结构和功能,结果表明该序列与已报道的乳酸杆菌胞外多糖生物合成基因具有高度的同源性(>96%);对各阅读框功能预测分析发现,这6个基因主要编码参与胞外多糖合成中的多糖合成蛋白、糖链长度检测蛋白、UDP-葡萄糖-4-异构酶和糖基转移酶.本研究将为利用基因工程方法调控多糖的合成和产量提供理论依据.     

乳酸菌胞外多糖对人类肠道菌群的影响

胞外多糖(EPS)是微生物在生长代谢过程中分泌到细胞壁外及周围生长介质中的一类生物大分子物质。乳酸菌胞外多糖除了具有重要的加工优势外,如提高酸奶等乳制品的粘度、质地和口感,还具有重要的生理活性。本文重点介绍了乳酸菌胞外多糖的分类和主要生物活性,并从胞外多糖的益生元特性、作为肠道能源物质、对肠道细胞的粘附、调节肠道菌群多样性、调节肠道免疫五个方面综述了乳酸菌胞外多糖对人类肠道菌群的影响,同时对胞外多糖的后续研究提出了自己的建议。     

乳酸菌胞外多糖对人类肠道菌群的影响

摘要：胞外多糖（EPS）是微生物在生长代谢过程中分泌到细胞壁外及周围生长介质中的一类生物大分子物质。乳酸菌胞外多糖除了具有重要的加工优势外,如提高酸奶等乳制品的粘度、质地和口感,还具有重要的生理活性。本文重点介绍了乳酸菌胞外多糖的分类和主要生物活性,并从胞外多糖的益生元特性、作为肠道能源物质、对肠道细胞的粘附、调节肠道菌群多样性、调节肠道免疫五个方面综述了乳酸菌胞外多糖对人类肠道菌群的影响,同时对胞外多糖的后续研究提出了自己的建议。     

植物乳杆菌JLK0142胞外多糖对RAW264.7巨噬细胞和免疫抑制小鼠的免疫调节作用

【目的】研究植物乳杆菌JLK0142胞外多糖(EPS)对RAW264.7巨噬细胞和免疫抑制小鼠免疫活性的影响。【方法】从植物乳杆菌JLK0142培养液中分离纯化EPS,采用体外细胞培养,测定EPS对巨噬细胞增殖、吞噬活性和一氧化氮(NO)分泌的影响;采用环磷酰胺构建免疫抑制小鼠模型,灌胃不同剂量的EPS,分别测定小鼠脾脏指数、T淋巴细胞增殖活力及血清中IL-2和TNF-α水平。【结果】植物乳杆菌JLK0142胞外多糖在50–800μg/m L浓度范围内能促进正常状态RAW264.7巨噬细胞的增殖,显著提高巨噬细胞的吞噬活性及NO的分泌量;与模型组相比,EPS中、高剂量组小鼠脾脏指数和T淋巴细胞增殖活力显著提高;EPS高剂量组小鼠血清中IL-2和TNF-α含量显著提高。【结论】植物乳杆菌JLK0142胞外多糖能有效提高RAW264.7巨噬细胞的免疫活力,并拮抗环磷酰胺对小鼠免疫功能的抑制作用。     

Fermentation of prebiotics by human colonic microbiota in vitro and short-chain fatty acids production: a critical review

Prebiotics are known for their health benefits to man, including reducing cardiovascular disease and improving gut health. This review takes a critical assessment of the impact of dietary fibres and prebiotics on the gastrointestinal microbiota in vitro. The roles of colonic organisms, slow fermentation of prebiotics, production of high butyric and propionic acids and positive modulation of the host health were taken into cognizance. Also, the short-chain fatty acids (SCFAs) molecular signalling mechanisms associated with their prebiotic substrate structural conformations and the phenotypic responses related to the gut microbes composition were discussed. Furthermore, common dietary fibres such as resistant starch, pectin, hemicelluloses, β-glucan and fructan in context of their prebiotic potentials for human health were also explained. Finally, the in vitro human colonic fermentation depends on prebiotic type and its physicochemical characteristics, which will then affect the rate of fermentation, selectivity of micro-organisms to multiply, and SCFAs concentrations and compositions.     

In vitro production of short-chain fatty acids from resistant starch by pig faecal inoculum

The need to improve the knowledge of fermentation processes within the digestive tract in pigs is growing, particularly for ingredients that may act as potential prebiotic sources, such as resistant starch (RS). A study (based on enzymatic digestion followed by in vitro fermentation) was conducted to investigate whether various sources of RS, obtained from eight native starches characterized by inherent heterogeneous starch chemistry and structure, can influence short-chain fatty acid (SCFA) concentrations and relative production kinetics. Total and individual SCFA productions were evaluated over time and up to 72 h of incubation. The in vitro hydrolysis of native starches allowed a classification from very high [⩾650 g/kg dry matter (DM)] to low (<50 g/kg DM) RS amount. The total SCFA production was similar between ingredients, whereas acetate and butyrate molar ratios in the SCFA profile differed (from 0.48 to 0.56 and from 0.17 to 0.25, respectively; P < 0.05). Differences in fermentation kinetic parameters for total and individual SCFA productions were observed (P < 0.05). Considering the total SCFA production after 72 h of incubation, the time at which half of the maximum production has been reached (T_1/2), the maximum rate of production (R_max) and its time of occurrence (T_max) differed between ingredients (P < 0.05), with values ranging from 6.1 to 11.9 h, from 0.459 to 1.300 mmol/g DM incubated per hour and from 5.1 to 9.8 h, respectively. Overall, a similar trend was observed considering individual SCFA productions. In particular, T_1/2 ranged from 6.4 to 12.5 h, from 5.5 to 12.5 h and from 6.7 to 11.3 h for acetate, propionate and butyrate, respectively (P < 0.05). For R_max, differences were obtained for propionate and butyrate productions (P < 0.05), whereas no difference was recorded for acetate. In summary, our findings indicated that both quantitative and qualitative production of SCFA and related kinetics were influenced by fermentation of RS obtained from native starches characterized by heterogeneous starch characteristics. Current findings are based on an in vitro approach, and thus require further in vivo validations.     

The effect of sucrose or starch-based diet on short-chain fatty acids and faecal microflora in rats

An investigation was carried out to determine whether variations of dietary carbohydrates could modify the colonic flora in rats. Sprague-Dawley rats were fed with two equicaloric diets based on the AIN-76 diet (American Institute of Nutrition 1977) but differing from that diet in content of carbohydrates, i.e. high sucrose (64%) of high corn starch (64%). Feeding was continued for 9 months ad libitum and no variation in weight gain was recorded among the different diets. A prevalence of aerobes, and a significant reduction in the ratio anaerobes/aerobes in the faeces of rats on the high starch diet compared with the high sucrose diet, was observed. The anaerobe genera identified included Actinomyces, Bacteroides, Bifidobacterium, Clostridium, Eubacterium, Lactobacillus and Propionibacterium. Bacteroides was the most prevalent genus in both dietary groups (51.2 and 29.5% in the faeces of rats fed the sucrose and starch diets, respectively). In contrast, clostridia were prevalent in the starch-fed group (23.8%) and less so in the sucrose diet (11.5%), as propionibacteria were prevalent in faeces of rats fed the starch diet (15.5%), and low in the sucrose diet (3.9%). The remaining genera were scarce in faeces from rats on either diet. Total short-chain fatty acids (SCFA) were significantly higher in the faeces of animals fed the starch diet compared with those fed the sucrose diet. The relative concentrations of acetic, propionic and butyric acids were not significantly different between the two dietary groups. In conclusion, high starch diet can markedly modify the composition of faecal flora and alter considerably the faecal concentration of SCFAs, compound which might have a health-promoting effect.     

Evaluation of intestinal microbiota,short-chain fatty acids,and immunoglobulin a in diversion colitis

It is reported that an increase in aerobic bacteria, a lack of short-chain fatty acids (SCFAs), and immune disorders in the diverted colon are major causes of diversion colitis. However, the precise pathogenesis of this condition remains unclear. The aim of the present study was to examine the microbiota, intestinal SCFAs, and immunoglobulin A (IgA) in the diverted colon. Eight patients underwent operative procedures for colostomies. We assessed the diverted colon using endoscopy and obtained intestinal samples from the diverted colon and oral colon in these patients. We analyzed the microbiota and SCFAs of the intestinal samples. The bacterial communities were investigated using a 16S rRNA gene sequencing method. The microbiota demonstrated a change in the proportion of some species, especially Lactobacillus, which significantly decreased in the diverted colon at the genus level. We also showed that intestinal SCFA values were significantly decreased in the diverted colon. Furthermore, intestinal IgA levels were significantly increased in the diverted colon. This study was the first to show that intestinal SCFAs were significantly decreased and intestinal IgA was significantly increased in the diverted colon. Our data suggest that SCFAs affect the microbiota and may play an immunological role in diversion colitis.     

不同碳水化合物对孤独症患儿肠道菌群 体外发酵产生短链脂肪酸的影响

目的探究孤独症谱系障碍(autism spectrum disorder,ASD)患儿与健康儿童的肠道菌群利用不同碳水化合物产生短链脂肪酸(short-chain fatty acids,SCFAs)的差异。方法前瞻性病例对照研究。选择2016年12月至2017年10月解放军总医院儿科门诊的15例ASD患儿为研究对象,并匹配15名健康儿童为对照组;收集研究对象粪便,稀释成10%悬浊液,然后分别接种到以乳果糖(LAU)、乳糖(LAT)、棉籽糖(RAF)、低聚半乳糖(GOS)、低聚异麦芽糖(IMO)和低聚甘露糖(MOS)为单碳源的肠道微生态小型模拟发酵系统中批量发酵24 h,检测SCFAs浓度、底物降解率和产气气压。结果 ASD组患儿粪便SCFAs浓度与对照组差异无统计学意义,在YCFA(无碳源对照培养基,蛋白发酵为主)培养基发酵后总SCFAs、乙酸和丙酸均低于对照组,差异有统计学意义(Z=-2.509、-2.509、-3.007,P=0.011、0.011、0.002);在添加LAT、RAF、GOS、IMO和MOS的培养基发酵后总SCFAs浓度显著高于对照组,差异有统计学意义(Z=2.385、2.344、2.675、2.344、2.302,P=0.016、0.019、0.007、0.019、0.021),而含LAU的培养基发酵后,两组研究对象总SCFAs浓度比较差异无统计学意义。结论 ASD患儿肠道菌群利用蛋白发酵产SCFAs能力显著低于健康对照,利用碳水化合物产SCFAs能力显著高于健康对照。6种发酵底物中,乳果糖是最适合ASD患儿的碳水化合物,有改善ASD患儿肠道菌群产SCFAs的潜力。     

Effect of exogenous fatty acids on the growth and production of exopolysaccharides of obligately methylotrophic bacterium Methylophilus quaylei

Accelerating growth and increasing exopolysaccharide production in obligate methylotrophic bacterium Methylophilus quaylei were observed in the presence of C12-C18 fatty acids added to the growth media. Sodium oleate was the best growth factor. Based on data on the composition of the free fatty acids fraction in the cells and the values of the zeta-potential and fluorescence anisotropy of whole cells, we suggested that fatty acids were incorporated in the outer membrane of M. quaylei.     

Effect of exogenous fatty acids on the growth and production of exopolysaccharides of obligately methylotrophic bacterium Methylophilus quaylei

Accelerating growth and increasing exopolysaccharide production in obligate methylotrophic bacterium Methylophilus quaylei were observed in the presence of C₁₂–C₁₈ fatty acids added to the growth media. Sodium oleate was the best growth factor. Based on data on the composition of the free fatty acids fraction in the cells and the values of the ξ-potential and fluorescence anisotropy of whole cells, we suggested that fatty acids were incorporated in the outer membrane of M. quaylei.     

Responses of feeding prebiotics on nutrient digestibility, faecal microbiota composition and short-chain fatty acid concentrations in dogs: a meta-analysis

The effects of prebiotics on digestibility, short-chain fatty acid (SCFA) concentrations and bacterial populations in the faeces and immunity in dogs were evaluated by meta-analyses. Overall, data from 15 published studies containing 65 different treatment means of 418 observations from different breeds of dogs were included in the data set. Feeding of prebiotics to dogs did not affect the nutrient intake (P > 0.10), nor did prebiotics change (P > 0.10) the digestibility of dry matter (DM) and fat. However, crude protein (CP) digestibility tended to decrease quadratically (P = 0.06) with increasing dosages of prebiotics, although the degree of prediction was low (R(2) = 0.33). The concentration of total SCFA (P = 0.08; R(2) = 0.90) tended to increase linearly, whereas concentration of acetate (R(2) = 0.25), propionate (R(2) = 0.88) and butyrate (R(2) = 0.85) increased quadratically with increasing dosage of prebiotics in the faeces of dogs. The numbers of beneficial bifidobacteria (P < 0.01; R(2) = 0.62) increased quadratically, but lactobacilli (P < 0.01; R(2) = 0.66) increased linearly with increasing supplementation of prebiotics. The changes in healthy bacterial numbers were affected by the interaction of initial bacterial numbers and dose of prebiotics; bacterial numbers increased relatively more when initial bacterial numbers were low. Dietary composition did not influence the response of prebiotics on lactobacilli and bifidobacterial numbers in this study. The numbers of pathogenic Clostridium perfringens and Escherichia coli were not affected by prebiotics. Prebiotics did not affect the serum immunoglobulin (Ig) concentrations such as IgG, IgA and IgM in dogs. Although prebiotics may tend to have an adverse effect on CP digestibility, prebiotics at doses up to 1.40% food intake (DM basis) might increase the beneficial bacterial populations and SCFA concentrations in the faeces of dogs. Thus, the feeding of prebiotics has a great prospective to improve the intestinal health of dogs.